REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro De Epilepsia Neurotologia Y Sueno S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Secondary Activities: Ambulatory Health Care Services
Full name: Centro De Epilepsia Neurotologia Y Sueno S.A.S. Profile Updated: August 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Centro De Epilepsia Neurotologia Y Sueno S.A.S. is a company based in Colombia, with its head office in Neiva. It operates in the Diagnostic Imaging Centers industry. It was incorporated on April 23, 2010. The latest financial highlights indicate a net sales revenue increase of 8.33% in 2022. Its’ total assets recorded a growth of 13.38%. The net profit margin of Centro De Epilepsia Neurotologia Y Sueno S.A.S. increased by 0.4% in 2022.

Headquarters
Carrera 7A Nro. 10 - 44
Neiva; Huila;

Contact Details: Purchase the Centro De Epilepsia Neurotologia Y Sueno S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Centro De Epilepsia Neurotologia Y Sueno S.A.S. report to view the information.
Incorporation Date:
April 23, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro De Epilepsia Neurotologia Y Sueno S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
8.33%
Total operating revenue
8.33%
Operating profit (EBIT)
17.99%
Net Profit (Loss) for the Period
14.83%
Total assets
13.38%
Total equity
25.87%
Operating Profit Margin (ROS)
0.92%
Net Profit Margin
0.4%
Return on Equity (ROE)
-1.99%
Quick Ratio
3.2%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?